Alnylam Pharmaceuticals (ALNY) PT Lowered to $447 at Bernstein SocGen Group
May 1, 2026 9:52 AM
Bernstein SocGen Group analyst William Pickering lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $447.00 (from $448.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
